A FRAMEWORK FOR MEASURING ADHERENCE TO MULTIPLE MEDICATIONS
Author(s)
Pednekar P1, Agh T2, Raval A3, Malmenäs M4, Peterson AM5, Bennett B6, Abrahamyan L7, Bunz TJ2, Borah BJ8, Hutchinson D9, Hiligsmann M10, Manias E11, Williams A12, Turcu-Stiolica A13, Zeber J14
1University of the Sciences, Philadelphia, PA, USA, 2Syreon Research Institute, Budapest, Hungary, 3Healthcore, Inc., Wilmington, DE, USA, 4PAREXEL International, Stockholm, Sweden, 5University of the Sciences in Philadelphia, Philadelphia, PA, USA, 6Adelphi Values Ltd, Bollington, UK, 7University of Toronto, Toronto, ON, Canada, 8Mayo Clinic College of Medicine, Rochester, MN, USA, 9Pharmacy Networks, CVS Caremark, Scottsdale, AZ, USA, 10Maastricht University, Maastricht, The Netherlands, 11Deakin University, Burwood, Australia, 12Monash University, Clayton, Australia, 13Faculty of Pharmacy, University of Medicine and Pharmacy, Craiova, Romania, 14Center for Applied Health Research, Temple, TX, USA
Conference/Value in Health Info
Value in Health, Vol. 19, No. 7 (November 2016)
Code
AD2
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Multiple Diseases
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now